- Home
- NSC vs ZTS Comparison
NSC vs ZTS Comparison
Compare NSC & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSC
- ZTS
- Stock Information
- Founded
- NSC 1980
- ZTS 1952
- Country
- NSC United States
- ZTS United States
- Employees
- NSC N/A
- ZTS N/A
- Industry
- NSC Railroads
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- NSC Industrials
- ZTS Health Care
- Exchange
- NSC Nasdaq
- ZTS Nasdaq
- Market Cap
- NSC 61.7B
- ZTS 66.2B
- IPO Year
- NSC N/A
- ZTS 2013
- Fundamental
- Price
- NSC $277.21
- ZTS $146.31
- Analyst Decision
- NSC Buy
- ZTS Buy
- Analyst Count
- NSC 19
- ZTS 8
- Target Price
- NSC $285.56
- ZTS $200.25
- AVG Volume (30 Days)
- NSC 2.0M
- ZTS 2.4M
- Earning Date
- NSC 10-21-2025
- ZTS 11-03-2025
- Dividend Yield
- NSC 1.95%
- ZTS 1.37%
- EPS Growth
- NSC 87.40
- ZTS 14.10
- EPS
- NSC 14.81
- ZTS 5.82
- Revenue
- NSC $12,178,000,000.00
- ZTS $9,385,000,000.00
- Revenue This Year
- NSC $2.76
- ZTS $3.90
- Revenue Next Year
- NSC $4.42
- ZTS $6.00
- P/E Ratio
- NSC $18.70
- ZTS $25.17
- Revenue Growth
- NSC 0.71
- ZTS 5.27
- 52 Week Low
- NSC $201.63
- ZTS $139.70
- 52 Week High
- NSC $291.70
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- NSC 50.94
- ZTS 35.12
- Support Level
- NSC $268.23
- ZTS $148.38
- Resistance Level
- NSC $280.28
- ZTS $152.00
- Average True Range (ATR)
- NSC 3.53
- ZTS 2.81
- MACD
- NSC -0.69
- ZTS -0.81
- Stochastic Oscillator
- NSC 71.67
- ZTS 3.92
About NSC Norfolk Southern Corporation
Class-I railroad Norfolk Southern operates in the Eastern United States. On more than 20,000 miles of track, the rail hauls shipments of coal, intermodal traffic, and a diverse mix of automotive, agriculture, metal, chemical, and forest products.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.